UCSF study shows importance of pregnant women making informed decisions before undergoing genetic testing
A clinical trial led by UC San Francisco has found that when pregnant women are educated about their choices on prenatal genetic testing, the number of tests actually drops, even when the tests are offered with no out-of-pocket costs.
The findings underscore the need for clear information on all prenatal testing options and their possible outcomes, including the option of no testing, before pregnant women decide whether or not to have genetic testing, the authors said.
The study also suggests that some women may have undergone prenatal screening for Down syndrome without having full information about the implications of testing, the authors said.
The article is published in the September 24, 2014 issue of JAMA, the Journal of the American Medical Association.
"Our findings show that prenatal testing is not appropriate for everyone, and that all women need information that is readily understood and unbiased to enable them to make informed choices reflecting their own preferences and values," said lead author Miriam Kuppermann, PhD, MPH, professor and vice chair for clinical research at the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences.
"Decisions about prenatal testing are personal and should be reflective of the patient's own values and preferences, not those of her health-care providers," said Kuppermann.
Since the introduction of amniocentesis in the 1970s, prenatal genetic testing guidelines have largely centered on identifying women at higher risk of giving birth to an infant with Down syndrome or other chromosomal abnormalities, to whom diagnostic testing should be offered. Professional societies, including the American College of Obstetricians and Gynecologists, recommend that patients of all ages be given detailed information on both screening and diagnostic tests -- and the conditions to be tested for -- in order to help patients make informed decisions.
Approximately four million babies are annually born in the United States. Of those, about 6,000 babies, or one in 700, are born with Down syndrome.
The goal of the UCSF randomized clinical trial was to determine the types of choices women of varying backgrounds would make "after being fully informed about the benefits and risks of differing prenatal testing strategies and having the opportunity to clarify their values around these options."
The research was conducted at three county hospitals in the San Francisco region, along with one community clinic that primarily serves low-income women, one academic center and three medical centers of an integrated health care delivery system.
It involved 710 English or Spanish-speaking women who were a maximum of 20 weeks pregnant with twins or a single baby and had not previously undergone prenatal testing in the current pregnancy. Participants were enrolled in the study between January 2010 and June 2012 and were followed through their deliveries; the last delivery occurred in January 2013.
Half the women were randomly assigned to the intervention group, which included access to an interactive decision-support guide and to prenatal testing with no out-of-pocket expenses. The other half were provided with the usual prenatal care. No matter their age, all the women – consistent with current guidelines – were informed that prenatal diagnostic testing was an option.
The researchers found that on average, women who were assigned to the intervention group were less likely to undergo diagnostic testing – 5.9 percent versus 12.3 percent. Additionally, the women in this group scored significantly higher for knowledge of genetic testing, and were more likely to correctly report both the miscarriage risk of amniocentesis and their likelihood of carrying a fetus with the chromosomal abnormality that causes Down syndrome.
"This does not mean that women in general don't want testing," said Kuppermann. "But it does suggest that at least some women have undergone testing without having clarity about the implications. As prenatal testing becomes easier with cell-free DNA testing, a highly accurate blood test for Down syndrome, it is particularly important that women understand the implications of having this test so they can decide whether or not to opt for it."
From UCSF, the authors include Sherri Pena, MS; Judith T. Bishop, CNM; Sanae Nakagawa, MA; Juan Vargas, MD; and Mary E. Norton, MD, of the Department of Obstetrics, Gynecology and Reproductive Sciences; and Steven E. Gregorich, PhD, a statistician faculty member of the Department of Medicine.
The study was funded by grants from the National Institutes of Health (R01HD049686) and the March of Dimes Foundation.
UCSF is the nation's leading university exclusively focused on health. Now celebrating the 150th anniversary of its founding as a medical college, UCSF is dedicated to transforming health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with world-renowned programs in the biological sciences, a preeminent biomedical research enterprise and two top-tier hospitals, UCSF Medical Center and UCSF Benioff Children's Hospital San Francisco. Please visit http://www.ucsf.edu.
Elizabeth Fernandez | Eurek Alert!
23.03.2017 | Technische Universität München
How prenatal maternal infections may affect genetic factors in Autism spectrum disorder
22.03.2017 | University of California - San Diego
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
23.03.2017 | Life Sciences
23.03.2017 | Power and Electrical Engineering
23.03.2017 | Earth Sciences